RESUMEN
BACKGROUND & AIMS: Liver transplantation (LT) is one of the most complex surgical procedures. Enhanced recovery after surgery (ERAS) aims to reduce the risk of postoperative complications. When patients achieve all desirable outcomes after a procedure, they are considered to have experienced a textbook outcome (TO). METHODS: Two cohorts of patients undergoing low (n = 101) or medium risk (n = 15) LT were identified. The remaining patients (n = 65) were grouped separately. The ERAS protocol included pre-, intra-, and post-operative steps. TO was defined as the absence of complications, prolonged length of hospital stays, readmission and mortality during the first 90 days. RESULTS: One third of patients who underwent ERAS after LT experienced a TO. On multivariable analysis, age (OR, 1.05 [95% CI, 1.01-1.09]; P = .02), and having hepatocellular carcinoma (OR, 2.83 [95% CI, 1.37-6.03]; P = .005) were individually associated with a greater probability of achieving a TO. Belonging to the cohorts of medium risk or outside the selection criteria was associated with a lower probability of achieving a TO (OR, 0.46 [96% CI, 0.22-0.93]; P = .03). Patients less likely to experience TO required more hospital resources. Patients who achieved TO were more likely to remain free of chronic kidney disease (achieved TO, 83.8% [82.7-85.6]; failed TO, 67.9% [66.9-70.2]; P < .05). Tacrolimus dose and trough levels were similar. CONCLUSIONS: A novel finding of our study is that short and medium-term kidney function is better preserved in patients who experience a TO. Better kidney function of patients who achieve TO is not due to lower tacrolimus dosage.
Asunto(s)
Recuperación Mejorada Después de la Cirugía , Neoplasias Hepáticas , Trasplante de Hígado , Humanos , Tiempo de Internación , Neoplasias Hepáticas/etiología , Trasplante de Hígado/efectos adversos , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Estudios RetrospectivosRESUMEN
BACKGROUND: Enhanced Recovery After Surgery (ERAS) is a multimodal, evidence-based, program of care developed to minimize the response to surgical stress, associated with reduced perioperative morbidity and hospital stay. This study presents the specific ERAS Society recommendations for liver transplantation (LT) based on the best available evidence and on expert consensus. METHODS: PubMed and ClinicalTrials.gov were searched in April 2019 for published and ongoing randomized clinical trials on LT in the last 15 y. Studies were selected by 5 independent reviewers and were eligible if focusing on each validated ERAS item in the area of adult LT. An e-Delphi method was used with an extended interdisciplinary panel of experts to validate the final recommendations. RESULTS: Forty-three articles were included in the systematic review. A consensus was reached among experts after the second round. Patients should be screened for malnutrition and treated whenever possible. Prophylactic nasogastric intubation and prophylactic abdominal drainage may be omitted, and early extubation should be considered. Early oral intake, mobilization, and multimodal-balanced analgesia are recommended. CONCLUSIONS: The current ERAS recommendations were elaborated based on the best available evidence and endorsed by the e-Delphi method. Nevertheless, prospective studies need to confirm the clinical use of the suggested protocol.
Asunto(s)
Recuperación Mejorada Después de la Cirugía , Trasplante de Hígado , Humanos , Tiempo de Internación , Trasplante de Hígado/efectos adversos , Atención Perioperativa/métodos , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Estudios ProspectivosRESUMEN
BACKGROUND & AIMS: Few studies have fully applied an enhanced recovery after surgery (ERAS) protocol to liver transplantation (LT). Our aim was to assess the effects of a comprehensive ERAS protocol in our cohort of low- and medium-risk LT patients. METHODS: The ERAS protocol included pre-, intra-, and post-operative steps. During the five-year study period, 181 LT were performed in our institution. Two cohorts were identified: low risk patients (n = 101) had a laboratory model for end-stage liver disease (MELD) score of 20 points or less at the time of LT, received a liver from a donor after brain death, and had a balance of risk score of 9 points or less; medium-risk patients (n = 15) had identical characteristics except for a higher MELD score (21-30 points). In addition, we analyzed the remaining patients (n = 65) who were transplanted over the same study period separately using the ERAS protocol. RESULTS: The low-risk cohort showed a low need for packed red blood cells transfusion (median: 0 units) and renal replacement therapy (1%), as well as a short length of stay both in the intensive care unit (13 h) and in the hospital (4 days); morbidity during one-year follow-up, and probability of surviving to one year (89.30%) and five years (76.99%) were in line with well-established reference data. Similar findings were observed in the medium-risk cohort. CONCLUSIONS: This single-center prospective observational cohort study provides evidence that ERAS is feasible and safe for low- and medium-risk LT.
Asunto(s)
Recuperación Mejorada Después de la Cirugía , Trasplante de Hígado/efectos adversos , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de RiesgoRESUMEN
Bacterial (bact)DNA is an immunogenic product that frequently translocates into the blood in cirrhosis. We evaluated bactDNA clearance in patients undergoing liver transplantation (LT) and its association with inflammation and clinically relevant complications. We prospectively included patients consecutively admitted for LT in a one-year follow-up study. We evaluated bactDNA before and during the first month after LT, quantifying cytokine response at 30 days. One hundred patients were included. BactDNA was present in the blood of twenty-six patients undergoing LT. Twenty-four of these showed bactDNA in the portal vein, matching peripheral blood-identified bactDNA in 18 cases. Thirty-four patients showed bactDNA in blood during the first month after LT. Median TNF-α and IL-6 levels one month after LT were significantly increased in patients with versus without bactDNA. Serum TNF-α at baseline was an independent risk factor for bactDNA translocation during the first month after LT in the multivariate analysis (Odds ratio (OR) 1.14 [1.04 to 1.29], P = 0.015). One-year readmission was independently associated with the presence of bactDNA during the first month after LT (Hazard ratio (HR) 2.75 [1.39 to 5.45], P = 0.004). The presence of bactDNA in the blood of LT recipients was not shown to have any impact on complications such as death, graft rejection, bacterial or CMV infections. The rate of bactDNA translocation persists during the first month after LT and contributes to sustained inflammation. This is associated with an increased rate of readmissions in the one-year clinical outcome after LT.
Asunto(s)
Traslocación Bacteriana/fisiología , ADN Bacteriano/sangre , Interleucina-6/sangre , Trasplante de Hígado , Factor de Necrosis Tumoral alfa/sangre , Disbiosis/microbiología , Femenino , Microbioma Gastrointestinal/fisiología , Tracto Gastrointestinal/microbiología , Humanos , Inflamación/microbiología , Cirrosis Hepática/patología , Cirrosis Hepática/cirugía , Masculino , Persona de Mediana Edad , Vena Porta/microbiología , Estudios Prospectivos , Factores de RiesgoRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Paniculitis Peritoneal/diagnóstico , Síndrome del Colon Irritable/diagnóstico , Diagnóstico Diferencial , Apnea Obstructiva del Sueño/complicaciones , Tamoxifeno/uso terapéuticoAsunto(s)
Enfermedades del Colon/diagnóstico , Infecciones por Escherichia coli/diagnóstico , Paniculitis Peritoneal/diagnóstico , Infecciones por Pseudomonas/diagnóstico , Antibacterianos/uso terapéutico , Biopsia , Colitis Isquémica/diagnóstico , Colitis Isquémica/etiología , Colitis Isquémica/cirugía , Enfermedades del Colon/epidemiología , Enfermedades del Colon/microbiología , Enfermedades del Colon/patología , Enfermedades del Colon/terapia , Colonoscopía , Colostomía , Terapia Combinada , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/cirugía , Hemorragia Gastrointestinal/etiología , Humanos , Mucosa Intestinal/patología , Masculino , Meropenem , Mesenterio/patología , Persona de Mediana Edad , Morfina/uso terapéutico , Paniculitis Peritoneal/epidemiología , Paniculitis Peritoneal/microbiología , Paniculitis Peritoneal/terapia , Nutrición Parenteral Total , Prednisona/uso terapéutico , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/cirugía , Tamoxifeno/uso terapéutico , Tienamicinas/uso terapéutico , ViajeRESUMEN
El trabajo tiene como fin buscar la eficiencia de los recursos destinados a los gastos de bienes, servicios y obras necesarias para el buen funcionamiento del Estado, debe ser del interés de la ciudadanía y no sólo del Ministerio de Economía y Finanzas Públicas que tiene limitaciones para hacer segumiento a más de 850 mil Contratos...